Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study

CONCLUSIONS: PIP prevalence is still high among French older adults, with substantial direct costs. Large scale interventions targeting most prevalent and/or costly PIPs are needed to reduce their clinical and economic impact.PMID:34525899 | DOI:10.1080/14737167.2021.1981863

Source: Expert Review of Pharmacoeconomics and Outcomes Research - September 16, 2021 Category: Health Management Authors: Barbara Roux Julien Bezin Camille Morival Pernelle Noize Marie-Laure Laroche Source Type: research